More than 200,000 young people have faced delays to cancer treatment in the last decade, according to figures seen exclusively by The Herald.

Mary George, an Ayyappankavu resident, has not gone out much as she has been under treatment for breast and spine cancer.

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...

If you have been diagnosed with metastatic breast cancer, resources like support groups, counseling, financial assistance, and online communities can help.

Breast cancer has long been a significant health concern for women, but recent trends show an unsettling increase in ...

With advanced equipment and expanded services, Laredo's Women's Imaging Center addresses diagnostic delays, offering ...

Following a world-first approval in Japan, AstraZeneca and Daiichi Sankyo’s second antibody-drug conjugate has crossed the ...

The Galleri test — which isn’t covered by insurance — doesn’t come cheap. At $949 a pop, it’s out of the price range of most ...

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...